JDI releases a patient video to demystify the role of Radioactive Iodine in the treatment of Differentiated Thyroid Cancer (DTC)

Jubilant DraxImage is pleased to announce the launch of its first video series focused on one of the fastest growing cancers in North America: thyroid cancer. The production of this video was made possible by the invaluable contribution of thyroid cancer survivors; patient advocacy groups ThyCa (U.S.) and Thyroid Cancer Canada (Canada), as well as a world renowned expert in the field of radioiodine ablation therapy: Dr. Douglas Van Nostrand, M.D.

Recently filmed at our Montréal manufacturing facility, this educational video seeks to demystify Radioiodine Ablation Therapy (RAI) so that patients and their families better understand the role of RAI in the treatment of DTC. Ultimately, patients must play an important role in the management of their thyroid disease, and proper patient education is an important factor in making an informed decision.

To learn more about thyroid cancer, please visit:

ThyCa: Thyroid cancer Survivors’ Association Inc.  http://thyca.org/home/

Leave a Reply

Share this news!